Ke Hu

Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China

J. Zhang, X. Wang, Xuemei Jia et al. · Clinical Microbiology and Infection · 2020 · 747 citations · Full text

Veterinary Medicine, Health Sciences, Infectious Diseases +14

Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial

Ke Hu, Wei‐jie Guan, Ying Bi et al. · Phytomedicine · 2020 · 463 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +10

Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial

Marco Boscaro, W.H. Ludlam, Brew Atkinson et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 279 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +15

Oseltamivir Compared With the Chinese Traditional Therapy Maxingshigan–Yinqiaosan in the Treatment of H1N1 Influenza

Chen Wang, Bin Cao, Qingquan Liu et al. · Annals of Internal Medicine · 2011 · 265 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Clinical characteristics of 82 death cases with COVID-19

Bicheng Zhang, Xiaoyang Zhou, Yanru Qiu et al. · medRxiv · 2020 · 249 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +16